Clinical Trial Update: FS120 Phase 1/1b Study in Patients With Advanced Malignancies [Phase 1]

View source ↗

Summary

FS120 is being studied in a Phase 1/1b trial for patients with advanced or metastatic cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• FS120

Snippet

Sponsor: invoX Pharma Limited | Conditions: Advanced Cancer, Metastatic Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING